This is a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of HTU-520 in subjects with clinically diagnosed onychomycosis of the great toenail.
A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety \& Efficacy of HTU-520 in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
182
Terbinafine hydrochloride patch
Treatment with Placebo Patch
Determination of status with respect to complete cure (mycological cure together with clinical cure) of onychomycosis of the toenail.
Time frame: 48 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Total Skin and Beauty Dermatology Center
Birmingham, Alabama, United States
Radiant Research, Inc.
Birmingham, Alabama, United States
UAB Department of Dermatology
Birmingham, Alabama, United States
University of Alabama at Birmingham
Birmingham, Alabama, United States
Clinical Research Advantage, Inc.
Glendale, Arizona, United States
Radiant Research, Inc.
Tucson, Arizona, United States
Diagnamics, Inc.
Encinatas, California, United States
Radiant Research, Inc.
Denver, Colorado, United States
Center for Clinical and Cosmetic Research
Aventura, Florida, United States
Marta Rendon, MD, Skin Care Research, Inc.
Boca Raton, Florida, United States
...and 27 more locations